Two for the Price of One: A Case of Methicillin-Resistant Staphylococcus aureus (MRSA) Brain Abscess With Atypical

Frailyn J Nunez1, Shorabh Sharma1, Michelle Dahdouh2

  • 1Internal Medicine, SBH (St. Barnabas Hospital) Health System, Bronx, USA.

Cureus
|February 6, 2023
PubMed

Insights

A cerebellar mass in an HIV patient was caused by methicillin-resistant Staphylococcus aureus (MRSA) infection. Pathology revealed atypical lymphoplasmacytic infiltrates, suggesting a potential precursor to central nervous system (CNS) lymphoma.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Oncology

Background:

  • Human immunodeficiency virus (HIV) infection can present with diverse central nervous system (CNS) symptoms due to multiple coexisting etiologies.
  • Cerebellar masses in HIV patients require thorough investigation to differentiate infectious from neoplastic processes.

Observation:

  • A 36-year-old male with HIV presented with headache and photophobia, exhibiting dilated pupils and anisocoria.
  • Brain imaging revealed a left cerebellar hemisphere mass with vasogenic edema, mass effect, and mild hydrocephalus.
  • Surgical evacuation of the cerebellar lesion yielded methicillin-resistant Staphylococcus aureus (MRSA) on tissue culture.

Findings:

  • Pathological examination of the cerebellar lesion showed atypical lymphoplasmacytic infiltrates.
  • While the predominant finding was a polyclonal B-cell population, atypical peaks suggested a possible clonal lymphoproliferative process.
  • The coexistence of MRSA infection and atypical lymphoplasmacytic infiltrates raised concerns for a precursor to CNS lymphoma.

Implications:

  • This case highlights the complex interplay of infectious and lymphoproliferative processes in the CNS of HIV-infected individuals.
  • Accurate diagnosis is crucial, as differentiating MRSA abscess from CNS lymphoma or other infiltrative processes can be challenging.
  • Further investigation into clonal lymphoproliferative processes as a potential complication or co-morbidity in HIV patients with CNS lesions is warranted.